British Association of Dermatologists Biologic Interventions Register delivers: infliximab increases risk of serious infections

Linked Article: Yiu et al. Br J Dermatol 2019; 180:329–337.

Saved in:
Bibliographic Details
Published inBritish journal of dermatology (1951) Vol. 180; no. 2; pp. 257 - 258
Main Author Puig, L.
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.02.2019
Subjects
Biological Products
Dermatologists
Humans
Immunotherapy
Infliximab
Ireland
Monoclonal antibodies
Psoriasis
TNF inhibitors
Tumor necrosis factor-α
Ireland
Online AccessGet full text

Cover

More Information
Summary:Linked Article: Yiu et al. Br J Dermatol 2019; 180:329–337.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Commentary-1
ISSN:0007-0963
1365-2133
DOI:10.1111/bjd.17437